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Abstract 
An ageing global population combined with sedentary lifestyles and unhealthy diets has 
contributed to an increasing incidence of obesity and type 2 diabetes. These metabolic 
disorders are associated with perturbations to nitric oxide (NO) signaling and impaired 
glucose metabolism. Dietary inorganic nitrate, found in high concentration in green leafy 
vegetables, can be converted to NO in vivo and demonstrates anti-diabetic and anti-obesity 
properties in rodents. Alongside tissues including skeletal muscle and liver, white adipose 
tissue is also an important physiological site of glucose disposal. However, the distinct 
molecular mechanisms governing the effect of nitrate on adipose tissue glucose metabolism, 
and the contribution of this tissue to the glucose tolerant phenotype, remain to be determined. 
Using a metabolomic and stable-isotope labeling approach, combined with transcriptional 
analysis, we found that nitrate increases glucose uptake and oxidative catabolism in primary 
adipocytes and white adipose tissue of nitrate-treated rats. Mechanistically, we determine that 
nitrate induces these phenotypic changes in primary adipocytes through the xanthine 
oxidoreductase catalysed reduction of nitrate to nitric oxide and independently of Peroxisome 
Proliferator-$FWLYDWHG 5HFHSWRUĮ. The nitrate-mediated enhancement of glucose uptake and 
catabolism in white adipose tissue may be a key contributor to the anti-diabetic effects of this 
anion. 
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According to the World Health Organization, there will be more than 650 million people 
worldwide with type 2 diabetes mellitus (T2D) by 2040. A lack of bioavailable nitric oxide 
(NO) observed in patients with T2D is considered a significant contributing risk factor for 
cardiovascular ill health (1). Polymorphisms in the endothelial-NOS (eNOS) gene, 
responsible for in vivo NO production, are associated with cardiovascular disease, T2D and 
insulin resistance in humans (2), supporting the view that perturbation of NO homeostasis 
contributes to the metabolic syndrome. Furthermore, eNOS-deficient mice are hypertensive, 
dyslipidemic, insulin resistant and glucose intolerant (3). Inorganic nitrate, found in high 
concentrations in green leafy vegetables, can be reduced in vivo to form NO. Complementary 
studies of dietary nitrate administration to the eNOS-deficient mouse and Sprague-Dawley 
rats report reduced adiposity and improved glucose and insulin homeostasis following nitrate 
treatment (4; 5). Inversely, long-term dietary nitrate deficiency induced the metabolic 
syndrome in mice (6). Therefore, nitrate may provide a therapeutic avenue for the treatment 
of aspects of the metabolic syndrome.  
Recently, the mechanisms behind the beneficial metabolic effects of nitrate have been 
explored. In skeletal muscle nitrate induces effects associated with endurance exercise 
WUDLQLQJ LQFOXGLQJ IDWW\ DFLGȕ-oxidation and fibre-type switching (7; 8) which may contribute 
to observations that nitrate improves exercise tolerance (9).  In the liver, nitrate may prevent 
steatohepatitis through effects on ȕ-oxidation and lipogenesis (10). 
In white adipose tissue (WAT), nitrate induces the browning response DQGȕ-oxidation (11). 
Whether nitrate directly regulates glucose metabolism in WAT remains unknown. We use 
metabolic profiling to identify a distinct glucose metabolic phenotype associated with WAT 
of nitrate-treated rats. We characterise the effect of nitrate on glucose uptake and metabolism 
in primary adipocytes using stable-isotope substrate labeling and define the mechanisms 
through which nitrate regulates glucose metabolism in WAT.  This study provides evidence 
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for a novel mechanism in WAT through which nitrate may mediate glucose metabolism. 
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Methods 
Animal experimentation. Male Wistar rats (6 weeks old) (269 ± 2 g; n = 12) (Charles River 
Laboratories) were weight matched and received either distilled water containing 0.7 mM 
NaCl or water containing 0.7 mM sodium nitrate (NaNO3) (Ultra-pure, Sigma-Aldrich) ad 
libitum for 18 days with food and water intake monitored (n = 6 / group).  Animals were 
housed in conventional cages at room temperature with a 12-hour/12-hour light/dark 
photoperiod. 
 
All procedures involving live animals were carried out by a licence holder in accordance with 
UK Home Office regulations, and underwent review by the University of Cambridge Animal 
Welfare and Ethical Review Committee. The rats used in this work were also used in 
separate, but parallel studies (8; 11), with a view to reducing the total numbers of animals 
used in accordance with UK Home Office best practice. Where relevant data (e.g. nitrate 
intakes has been reported previously, we refer to the previous paper (Supplementary Table 1). 
 
Tissue collection. Rats were fasted overnight and then euthanized with sodium pentobarbital 
(200 mg/ml, Vétoquinol UK Ltd.). Blood was taken by cardiac puncture and processed for 
plasma and WAT was removed and frozen in liquid nitrogen. 
 
Culture and differentiation of primary adipocytes. Primary WAT stromal vascular cells 
were fractionated from 6 ± 10 week old C57BL6 mice or 33$5ĮQXOO PLFH Ppara null mice 
were a kind gift of Frank Gonzalez [National Institutes of Health (NIH), Bethesda, MD, 
USA]) as previously described (11; 12).  &HOOV ZHUHFRXQWHG XVLQJ D6FHSWHU&HOO &RXQWHU
(MillipRUH DFFRUGLQJ WRWKHPDQXIDFWXUHU¶V LQVWUXFWLRQV &HOOV ZHUHVHHGHGDWFP2. 
Cells were then cultured and differentiated into adipocytes according to published methods 
(11; 12).  During the 6 day differentiation, cells were cultured with either saline (control) or 
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ȝ01D123 (Ultra-pure, Sigma-Aldrich) or 2-Phenyl-4,4,5,5-tetramethylimidazoline-1-
oxyl 3-oxide (PTIO ȝ0 RU.7ȝ0) (Santa Cruz Biotechnology) or 100 nM 
insulin. Cells were treated with PTIO, KT5823 and insulin ZLWK DQGZLWKRXW ȝ01D123. 
NaNO3 was added at day 1 and PTIO or KT5823 at day 5 of differentiation. For both Glut4 
membrane biotinylation and immunoprecipitation assays and insulin-stimulated glucose 
uptake assays, after differentiation, primary mouse adipocytes were serum starved for 4 hours 
before being treated with 100 nM insulin, 500 ȝ0Qitrate or both 100 nM insulin and 500 ȝ0 
nitrate together for 10 mins.   
 
Cell viability. Cell viability was determined using a resazurin assay. Briefly, cells were 
washed with pKRVSKDWH EXIIHUHG VDOLQH DQGLQFXEDWHG ZLWK ȝ0UHVD]XULQ LQ FXOWXUH PHGLD
for 2 hrs. Resazurin fluorescence was then measured (excitation 530 nm, emission 590 nm, 
cut-off 550 nm) with a fluorescence microplate reader. 
 
siRNA xanthine oxidoreductase knockdown. FlexiTube siRNA against XOR, AllStars 
negative control siRNA and HiPerFect Transfection Reagent were purchased from Qiagen. 
Adipocyte transfection was carried out as SHUWKHPDQXIDFWXUHU¶V LQVWUXFWLRQV 75 ng siRNA, 
ȝOWUDQVIHFWLRQ UHDJHQW SHUZHOO Q0ILQDO VL51$ FRQFHQWUDWLRQ RQGD\DQGRI
differentiation.  
 
Primary adipocyte 13C-glucose substrate labeling. Following the six-GD\ ȝ01D123 
treatment during differentiation, cells were cultured in low-glucose serum free media 
supplemented with U-13C-labelled glucose (3100 mg/L) for 24 hours. Cellular metabolites 
were then extracted and analysed by Gas Chromatography-Mass Spectrometry (GC-MS) as 
described below. 
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Metabolite extraction. Metabolites were extracted from WAT, blood plasma and primary 
adipocytes using a modified Bligh and Dyer method (14). Frozen WAT (20 mg) was 
pulverized using a Tissue Lyser II (Qiagen). Methanol-FKORURIRUP  ȝOZDVDGGHGWR
WKH:$7SODVPD ȝORUSULPDU\ DGLSRF\WHV DQGWKHVDPSOHV ZHUHVRQLFDWHG IRU 
minutes. Chloroform-water (1:1) was then added (4ȝO6DPSOHV ZHUHFHQWULIXJHG 
g, 20 minutes) the aqueous phase was separated, dried under nitrogen and stored at -80°C 
until analysis.  
 
GC-MS analysis. Dried aqueous phase samples were derivatized using methoxyamine 
hydrochloride solution (20 mg/ml in pyridine; Sigma-$OGULFK DQGȝORI1-methyl-N-
trimethylsilyltrifluoroacetamide (Macherey-Nagel, Duran, Germany) using the method 
described previously (14). GC-MS and data analysis were performed according to published 
methods (14). All GC-MS analyses were made using a Trace GC Ultra coupled to a Trace 
DSQ II single-quadrupole mass spectrometer (Thermo Scientific, Cheshire, UK). Derivatized 
aqueous samples were injected with a split ratio of 10 onto a 30 m × 0.25 mm 5% 
phenylpolysilphenylene-VLOR[DQH FROXPQ ZLWK DȝP=%-5 ms stationary phase 
(Phenomenex). The injector temperature was 230°C, and the helium carrier gas was used at a 
flow rate of 1.2 ml/min. The initial column temperature of 70°C was increased by 10°C/min 
to 130°C and then increased at a rate of 5°C/min to 230°C followed by an increase of 
20°C/min to 310°C and held for 5 min [transfer line temperature = 250°C; ion source = 
250°C; electron ionization (EI) = 70 eV]. The detector was turned on after 240 s, and full-
scan spectra were collected using 3 scans/s over a range of 50±650 m/z. 
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GC-MS chromatograms were processed using Xcaliber (version 2.0; Thermo Scientific). 
Each individual peak was integrated and then normalized. Overlapping peaks were separated 
using traces of single ions. Peak assignment was based on mass fragmentation patterns 
matched to the National Institute of Standards and Technology (USA) library and to 
previously reported literature.  
 
Gene expression analysis. Total RNA extraction from WAT and adipocytes, cDNA 
conversion and quantitative RT-PCR was performed according to published protocols (12). 
All data were normalized to 18SrRNA (mouse primary adipocytes) or RLPL1 (rat WAT) and 
TXDQWLWDWLYH PHDVXUHV REWDLQHG XVLQJ WKHǻ-ǻ-CT method.  
 
Biotinylation, immunoprecipitation and Western blot of cell surface Glut4. Surface 
Glut4 biotinylation, immunoprecipitation and Glut4 Western blot were carried out according 
to published protocols (15). Briefly, cells were incubated for 1 hour at 4°C with 0.5 mg/ml 
Biotin sulfo-NHS (Sigma-Aldrich). Cell lysates were pre-cleared by incubation for 30 
minutes with 0.5% (w/v) protein A-Sepharose. The protein A-Sepharose was pelleted by 
centrifugation for 1 minute at 13,000 g and the supernatant removed and incubated overnight 
with 0.5% (v/v) anti-Glut4 antibody (1F8, Cell Signaling). Protein A-Sepharose was added to 
0.5% (w/v) to the samples and incubation continued at 37°C for 1 hour. Immunocomplexes 
were pelleted at 13,000 g for 1 minute and the pellet washed three times with 50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS and 1% (v/v) 
Nonidet P-40. 
 
Immunoprecipitated biotinylated complexes were mixed with dissociation buffer (125 mM 
Tris-HCl, pH 6.8, 2% (w/v) SDS, 20% (v/v) glycerol, 100 mM dithiothreitol, Bromophenol 
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Blue) and boiled for 5 minutes. Glut4 was resolved by electrophoresis through 10% 
polyacrylamide gels, and then transferred to Hybond-P polyvinylidene difluoride membrane. 
The membrane was blocked for 1 hour in phosphate-buffered saline (PBS; 1.5 mM KH2PO4, 
2.7 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 5% (w/v) dried milk powder and 0.1% 
(v/v) Tween-20, followed by incubation with peroxidase-conjugated streptavidin [1:1000 
dilution in PBS containing 0.1% (v/v) Tween-20] for 1 hour. Bound peroxidase conjugates 
were visualised using an enhanced chemiluminescence detection system (Amersham 
Biosciences). Quantitation of immunoblots was performed using ImageJ. 
 
Glucose uptake assay. Cells were grown and differentiated in 96-well plates. Cells were 
ZDVKHGZLWK 'XOEHFFR¶V SKRVSKDWH EXIIHUHG VDOLQH '3%6 DQGSODFHGLQ ORZJOXFRVH J/
serum-free Dulbecco Modified Eagle Medium (DMEM) for 24 hours. Media was replaced 
with low glucose serum-free DMEM for 1 hour. Following media aspiration DPBS 
containing 6-deoxy-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (6-NBDG) (200 
ȝ0ZDVDGGHGIRU KRXU DQGFHOOV ZHUHNHSWDWºC, 5% CO2 Cells were washed three 
times with DPBS and fluorescence measured using a microplate reader (excitation 485 nm, 
emission 528 nm). 
 
Multivariate data analysis. Metabolomics data analysis was performed using Metaboanalyst 
version 4.0 (16). Data sets were auto scaled and analyzed using partial least squares-
discriminant analysis (PLS-DA). Metabolite changes responsible for clustering or regression 
trends within the pattern recognition models were identified by interrogating the 
corresponding loadings plot. Metabolites identified in the variable importance in 
projections/coefficients plots were deemed to have changed globally if they contributed to 
separation in the models with a confidence limit of 95%. Plasma metabolomics data was 
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analysed using univariate volcano plots with a fold change cut off of 1.2 and P-value cut off 
of 0.05 to identify significantly different metabolites. 
 
Data resource availability. All data including metabolomics datasets for GC-MS analysis of 
nitrate-treated rat adipose tissue and nitrate-treated primary adipocytes are available from the 
corresponding author on reasonable request.  
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Results 
Metabolomic profiling identifies nitrate-mediated effects on glucose metabolism in 
white adipose tissue  
Male Wistar rats were treated with either 0.7 mmol/L NaCl or 0.7 mmol/L NaNO3 via the 
drinking water for 18 days. Nitrate intake for the control group was 1 mg/kg/day compared 
with 8 mg/kg/day in the nitrate treated group, whilst water and food intake was not 
significantly different between the groups (Supplementary Table 1) (11). Metabolomic 
profiling and analysis using PLS-DA multivariate statistics identified a distinct metabolic 
signature differentiating subcutaneous inguinal WAT of nitrate-treated animals from controls 
(Fig. 1A). Interrogation of the corresponding loadings plots identified a distinct 
reprogramming of glucose and fatty acid metabolism in the WAT of nitrate treated rats (Fig 
1B). The decrease in the WAT concentration of the fatty acids propanoic, heptanoic, 
nonanoic, 3-hydroxyoctanoic, oleic, linoleic, and arachidonic acid in nitrate treated animals 
was consistent with our previous findings that nitrate drives WAT EURZQLQJ DQGȕ-oxidation 
(11). In a novel observation we identified a distinct glucose metabolism phenotype in the 
WAT of nitrate treated rats. The key glycolytic intermediates glucose 6-phosphate (Fig. 1C), 
and 3-phosphoglycerate (Fig 1D) alongside the pentose phosphate pathway ± glycolysis 
metabolite glycerate (Fig 1 E) and the pentose phosphate pathway metabolite D-altro-
heptulose (Fig 1F) were decreased in nitrate-treated rat WAT. Metabolic profiling of the 
plasma from nitrate treated animals indicated a corresponding decrease in glucose 
concentration (Fig 1 G & H). 
To investigate whether nitrate functions to increase glucose uptake and metabolism in 
adipose tissue, and possibly contribute to systemic glucose clearance, the expression of genes 
encoding the insulin-regulated glucose transporter type 4 (Glut4), the insulin- independent 
glucose transporter (Glut1) and a key rate regulating enzyme in glycolysis, hexokinase 2 
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(Hk2), which converts glucose to glucose 6-phosphate, was interrogated using RT-qPCR (Fig 
1i). Nitrate significantly increased the expression of these glucose import and metabolism 
genes. These data suggest that nitrate increases glucose uptake and disposal in adipose tissue. 
 
Nitrate increases glucose uptake and catabolism in white adipocytes 
To determine whether nitrate functions directly on WAT to increase glucose uptake and 
metabolism, stromal vascular fraction-derived primary adipocytes isolated from inguinal 
WAT of mice were treated with nitrate. A NaNO3 concentration of ȝ0ZDV chosen (11). 
Consistent with the results in vivo, metabolomic profiling identified that nitrate decreased the 
intracellular concentration of the glycolytic intermediates glucose 6-phosphate (Fig 2A) and 
3-phosphoglycerate (Fig 2B) in adipocytes. Nitrate treatment also significantly decreased the 
glucose concentration of the media (Fig 2C). The expression of genes key to glucose import 
and metabolism Glut4, Glut1 and Hk2 was increased in the nitrate-treated adipocytes (Fig 
2D). 
To functionally assess the effect on glucose metabolism observed in the WAT of nitrate 
treated rats, the stable isotope substrate U-13C-glucose was employed to evaluate enrichment 
of glucose-derived carbon through glucose import, the glycolytic pathway and into the TCA 
cycle. Primary adipocytes were incubated in serum-free media containing U-13C-glucose and 
treated with ȝ0 nitrate. GC-MS analysis was used to define the relative enrichment of 
metabolites. The labeled glucose enters the glycolytic pathway and is catabolized to pyruvate 
which is either converted to lactate, or labeled acetyl-CoA which enters the TCA cycle (Fig 
2E). An unlabeled metabolite is detected as the molecular ion (M) in the mass spectrum. 
Additional 13C-carbon atoms introduced to the specific molecule give rise to an increase in 
mass of 1 (M1, M2, M3, and so forth). Nitrate treatment increased the labeling of lactate (Fig 
13 
 
2F) and the M2 isotopologues of TCA cycle intermediates, citrate (Fig 2G), malate (Fig 2H) 
and the amino acid glutamate (Fig 2I), which is in fast exchange with 2-oxoglutarate from the 
TCA cycle. We noted a higher fractional enrichment of the M1 isotopologues of citrate (Fig. 
4H) in nitrate-treated adipocytes, which may be indicative of a moderate increase in malic 
enzyme (ME) activity.  Relative enrichment of the M3 isotopologues of TCA cycle 
intermediates was elevated in nitrate-treated cells (Fig. 2 H-I). Increased labelling of M3 
occurs through the action of pyruvate carboxylase (PC).   
In summary, nitrate confers a functional effect on adipocytes, not only increasing glucose 
uptake and flux through glycolysis but also oxidative catabolism. 
 
Nitrate increases plasma membrane Glut4 and insulin-stimulated glucose uptake in 
adipocytes 
We then investigated whether nitrate increased Glut4 presentation at the plasma membrane of 
primary adipocytes at baseline and following insulin-stimulation. Using a cell surface protein 
biotinylation and immunoprecipitation approach we identified that nitrate increased adipocyte 
plasma membrane Glut4 concentration (Fig 3A & B) (Supplementary Figure 1). We also 
observed that nitrate had an additive effect on plasma membrane Glut4 expression when 
combined with insulin (Fig 3A & 3B). Next, the functional uptake of glucose into adipocytes 
treated with nitrate was measured with the fluorescent glucose analog 6-NDBG in 
combination with insulin (100 nM) (Fig. 3C). Nitrate and insulin treatments did not affect cell 
viability (Supplementary Figure 2). Nitrate increased adipocyte glucose uptake and had an 
additive effect on insulin-stimulated glucose uptake into primary adipocytes.  
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Nitrate-induced expression of glucose metabolism genes is independent RI33$5Į in 
adipocytes  
We next probed the mechanisms through which nitrate mediates its effects on glucose 
metabolism in adipocytes. Several of the metabolic effects of nitrate, LQFOXGLQJ LQFUHDVHG ȕ-
oxidation and lactate dehydrogenase activity in muscle, occur through downstream 33$5Į
signalling (8; 17). We examined the effect of nitrate on glucose import and catabolic gene 
expression in primary adipocytes differentiated from the stromal vascular fraction of inguinal 
WAT from 33$5ĮQXOO mice. The lack RI33$5ĮKDGQRHIIHFW RQQLWUDWH-induced 
expression of glucose metabolism genes within the adipocytes (Fig 4A). Nitrate treatment 
significantly increased the expression of Glut4, Hk2 and Glut2. Thus, nitrate regulates 
glucose metabolic gene expression LQ DGLSRF\WHV LQGHSHQGHQWO\ RI33$5Į 
  
Nitrate promotes glucose uptake into adipocytes via nitrate-NO signaling  
NO can be generated in vivo from nitrate via XOR catalysed serial reduction of nitrate to 
nitrite and then to NO via the nitrate-nitrite-NO pathway (18; 19). We found nitrate induced 
the browning process in WAT through this pathway (11) . Therefore, we speculated that 
nitrate might be functioning via NO to increase glucose import and metabolism in WAT. 
Primary adipocytes were differentiated in the presence of nitrate and the NO scavenger PTIO. 
Nitrate and PTIO treatments did not affect cell viability (Supplementary Figure 3). PTIO 
abrogated the nitrate-induced expression of glucose metabolism genes, Glut4, Glut1 and Hk2 
(Fig 4B).  Next, the functional uptake of glucose into primary adipocytes treated with nitrate 
was measured with 6-NDBG in combination with PTIO (Fig. 4C). PTIO inhibited nitrate-
mediated glucose uptake into adipocytes. NO increases glucose uptake through the activity of 
cyclic GMP-dependent protein kinase G (PKG) (20). We have previously shown that nitrate 
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increases intracellular cGMP concentrations in adipocytes (11). We speculated that nitrate 
may signal via PKG to regulate adipocyte glucose metabolism. The pharmacological PKG 
inhibitor KT5823 blocked the nitrate-induced expression of Glut4, Glut1 and Hk2 in the 
adipocytes (Fig. 4D). These data demonstrate that nitrate signals via NO to enhance glucose 
uptake.  
As mentioned above the reduction of nitrate to NO in mammals can proceed via an enzymatic 
mechanism catalyzed by XOR (18; 19). XOR is expressed in WAT, and has a role in 
adipocyte homeostasis and the nitrate-induced browning mechanism (11; 21). To determine 
the role of this enzyme in the nitrate-mediated enhancement of glucose catabolism, XOR in 
primary adipocytes was knocked down using siRNA (Supplementary Fig 4) (11). Nitrate and 
XOR knockdown did not affect cell viability (Supplementary Figure 5). Knockdown of XOR 
abrogated the increased expression of glucose import and catabolism genes, Glut4, Glut1 and 
Hk2 in adipocytes treated with nitrate (Fig 4E). Functionally, the effect of XOR knockdown 
on glucose uptake into nitrate-treated primary adipocytes was measured using 6-NDBG (Fig 
4F). XOR knockdown inhibited nitrate-induced glucose uptake into primary adipocytes. 
These data indicate nitrate induces glucose uptake and oxidative catabolism in WAT via the 
XOR catalysed reduction of nitrate and downstream NO signaling.    
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Discussion 
Inorganic nitrate, found in high concentration in green leafy vegetables, may restore impaired 
NO signaling to treat aspects of cardiometabolic diseases including T2D (22). Nitrate 
regulates glucose homeostasis in rodent models of T2D (4-6; 23), however the mechanisms 
for nitrate-mediated improvements in metabolism remain to be fully elucidated. In WAT, 
nitrate promotes the browning response and enhanced fatty acid oxidation (11). The effects of 
nitrate on WAT glucose metabolism remained undefined. We are the first to determine that 
inorganic nitrate directly enhances both glucose uptake and oxidative catabolism through the 
activity of XOR, NO and PKG signaling. These findings are consistent with the effects of NO 
on glucose uptake, and Glut4 expression, in WAT (24-26). Interestingly, NO exhibits both 
insulin-dependent and insulin- independent effects on glucose uptake (24). We observe that 
nitrate enhances insulin-stimulated glucose uptake and plasma membrane expression of the 
insulin sensitive glucose transporter Glut4 in adipocytes. Nitrate also stimulates the 
expression of the insulin- independent transporter Glut1. This is consistent with our previous 
observation that nitrate induces WAT browning, since the browning phenomenon enhances 
Glut1 expression and may partly uncouple WAT glucose uptake from insulin action (27).   
Several of the metabolic effects of nitrate, including enhanced lactate dehydrogenase activity, 
LQ VNHOHWDO PXVFOH DQGKHDUW DUHPHGLDWHG WKURXJK WKHQXFOHDU UHFHSWRU33$5Į (8; 17). Our 
data show that nitrate-mediated expression of glucose uptake and metabolism genes was 
LQGHSHQGHQW RI33$5Į signaling. Nitrate¶s effects on Glut4, Glut1 and Hk2 were preserved in 
33$5Į-null adipocytes. This may, in part, reflect the low levels of expression of this nuclear 
receptor in WAT. 
Although both WAT browning and enhanced mitochondrial biogenesis aQGȕ-oxidation in 
muscle are likely to substantially contribute to the anti-obesity and anti-diabetic effects of 
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nitrate, increased glucose uptake and oxidative catabolism will be a distinct factor mediating 
the effect of the bioactive anion on glucose homeostasis.   
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Figure Legends 
Figure 1. Metabolic profiling identifies inorganic nitrate reprograms glucose 
metabolism in white adipose tissue. A) Partial least squares-discriminant analysis (PLS-
DA) plot showing the clustering of metabolites measured using GC-MS from adipose tissue 
of nitrate-treated rats (n = 6, green circles) compared with the control rats (n = 6, red circles 
(R2(X) = 99%, Q2 = 67%). 95% confidence regions are displayed. B) PLS-DA loadings plot 
showing separation of nitrate-treated rat adipose tissue is driven by a decrease in glucose 
metabolites and fatty acids. The concentration of C) glucose 6-phosphate, D) 3-
phosphoglycerate, E) glycerate and F) D-altro-heptulose in nitrate-treated rat adipose tissue 
normalised to control. G) Volcano plot of metabolic profiling data of nitrate-treated rat 
plasma (metabolite concentrations are higher in the control group). H) The concentration of 
glucose in nitrate-treated rat plasma normalised to control. I) The expression of glucose 
transporter (Glut 4 and Glut 1) and metabolism (Hk2) genes in nitrate-treated rat 
subcutaneous adipose tissue (n = 6). Bar graph data is displayed as Mean ± SEM. 3
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Figure 2. Nitrate enhances glucose catabolism in primary white adipocytes. The 
intracellular concentrations of, and representative chromatographic peaks for, A) glucose 6-
phosphate and B) 3-phosphoglycerate in nitrate-treated primary adipocytes normalised to 
control. The concentration of, and representative chromatographic peak for, C) glucose in the 
media of nitrate-treated primary adipocytes normalised to control. D) The expression of 
glucose transporter (Glut 4 and Glut 1) and metabolism (Hk2) genes in nitrate-treated (500 
ȝ0) primary adipocytes. E) Schematic representation of glucose carbon tracing through 
glycolysis, the TCA cycle, malic enzyme (ME1), pyruvate carboxylase (PC) and glutamate 
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dehydrogenase (GDH) reactions in control and nitrate-WUHDWHG ȝ0 primary adipocytes 
in presence of U-13C glucose. Ball diagrams indicate isotopologues. Open circles represent 
12C, black circles represent 13C through glycolysis and pyruvate dehydrogenase-initiated TCA 
cycle reactions. Green arrow indicates 13C from PC-initiated TCA reactions (subsequently 
identified by the green circles). Purple arrow indicates the ME1 pathway and purple circles 
represent 13C derived from the ME1 reaction.  Not all possible labeled metabolites are shown. 
Gas Chromatography-Mass Spectrometry stable isotope analysis of methoximation and 
silylation-derivatized F) lactate, G) citrate, H) malate and I) glutamate extracted from control 
DQGȝ0QLWUDWH-treated primary adipocytes. Graphs show the ratio enrichments in the 
metabolite isotopologues. The X-axis indicates the mass isotopomers (which are M1, 
0«0QZKHUH QLVWKHQXPEHU RIODEHOOHG DWRPV LQ WKHPROHFXOH LQ WKH VSHFLILHG
metabolites (corrected for13C natural abundance) (n = 4). Data is displayed as Mean ± SEM. 
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Figure 3. Nitrate enhances Glut4 expression at the cell membrane and insulin-
stimulated glucose uptake.  A) Immunoprecipitation blots of cell surface biotinylated Glut4 
from primary mouse adipocytes treated with ȝ0QLWUDWH with and without 100 nM insulin 
(n = 3).  B) Quantitation of cell surface biotinylated and immunoprecipitated Glut4 from 
primary mouse adipocytes treated with ȝ0nitrate with and without 100 nM insulin (n = 
3). C) *OXFRVH XSWDNHLQ SULPDU\ DGLSRF\WHV WUHDWHGZLWK ȝ0nitrate with and without 
100 nM insulin (n ). 'DWD LVGLVSOD\HG DV0HDQ6(033 
 
Figure 4. Nitrate promotes glucose import and metabolism through a xanthine 
oxidoreductase catalysed reduction of nitrate to nitric oxide. A) The expression of 
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glucose import (Glut4, Glut1) and catabolic (Hk2) genes in primary adipocytes differentiated 
from the stromal vascular fraction of inguinal WAT from 33$5Į null mice and treated with 
ȝ0QLWUDWH (n = 3). B) Glucose import and metabolism gene expression in primary 
adipocytes treated with the NO scavenger PTIO ȝ0) with and without 500 ȝM nitrate (n 
= 3). C) Glucose uptake in primary adipocytes treated with the NO scavHQJHU 37,2ȝ0) 
with and without 500 ȝM nitrate (n = 5). D) Glucose import and metabolism gene expression 
in primary adipocytes treated with the Protein Kinase G iQKLELWRU .7ȝ0) with and 
without 500 ȝM nitrate (n = 4). E) Glucose uptake and metabolism gene expression in 
primary adipocytes treated with negative control siRNA or siRNA against XOR with and 
ZLWKRXW ȝ01D123 (n = 3). F) Glucose uptake in primary adipocytes treated with 
QHJDWLYH FRQWURO VL51$RUVL51$ DJDLQVW ;25ZLWK DQGZLWKRXW ȝ01D123 (n ). 
'DWDLV GLVSOD\HG DV0HDQ6(03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